Study Title

Evaluation of 64Cu-ATSM PET/CT in Predicting Neo Adjuvant Treatment Response in Locally Advanced Rectum Cancer

Study Details

Description:

This phase II trial is assessing how 64Cu-ATSM (64Cu-copper(II) diacetylbis(N4-methylthiosemicarbazone)) PET/CT scan could predict neo adjuvant treatment response in rectum cancer locally advanced

Sponsor:

Institut Cancerologie de l'Ouest

Contacts:

Mathilde COLOMBIE, MD

mathilde.colombie@ico.unicancer.fr

+33240679900 ext 9501

Nadia ALLAM, PhD

nadia.allam@ico.unicancer.fr

+33240679826

Government Study Link:

NCT03951337 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468